Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test December 8, 2020December 9, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailQuantifying IgG is critical component to test population-wide vaccination effectiveness Related News: Molecular Devices launches automated workcells for…Roche to introduce its next-generation portfolio of…Roche receives CE Mark for new and updated molecular…Shimadzu Scientific Instruments and PACE Analytical…Roche launches new diagnostic test for the better…Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the…
